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CC BY-NC-ND license (http://creativSummary Coronary artery disease (CAD) is a major cause of morbidity and mortality in pa-
tients with end-stage renal disease (ESRD). Such a combination poses a considerable technical
challenge for revascularization because of multiple comorbidities and higher surgical risk.
Here, we conducted a literature review on different revascularization strategies, on-pump
and off-pump bypass grafting outcomes, harvested internal mammary artery numbers, and po-
tential complications (e.g., steal syndrome) in managing patients with ESRD and comorbid
CAD.
Copyright ª 2016, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Coronary artery disease (CAD) is a major cause of morbidity
and mortality in patients with end-stage renal disease
(ESRD). Despite the development of revascularizationbuting authors declare no
of Cardiovascular Surgery,
iwan University Hospital, 7
aiwan.
.com (Y.-S. Chen).
01.003
Surgical Association. Published
ecommons.org/licenses/by-nc-ndtherapies and refinement of surgical techniques in past
decades, the prognosis of patients with ESRD remains poor;
the estimated 5-year survival rate after dialysis initiation is
only approximately 34%.1 The most crucial cause of mor-
tality in these patients is cardiac disease, accounting for
39e45% of all deaths.2,3 Compared with nondialysis pa-
tients, patients with ESRD are more likely to have CAD, and
most cases are symptomatic multivessel CAD. Moreover, the
prevalence and incidence of ESRD are high in Taiwan.
Therefore, we conducted this review to determine the
survival outcomes and risk factors for mortality following
coronary artery bypass grafting (CABG) surgery.by Elsevier Taiwan LLC. This is an open access article under the
/4.0/).
Figure 1 End-stage renal disease KaplaneMeier survival
curve for patients without diabetes. Patients revascularized
with cardiopulmonary bypass have a long-term survival
advantage; the on-pump data lie above the United States Renal
Data System (USRDS) curve at all points.
Copyright 2006, Todd M. Dewey M.D., Reprinted with
permission.
46 C.-Y. Hsu, Y.-S. Chen2. Revascularization: percutaneous coronary
intervention versus CABG
The most appropriate method for revascularization is
debatable. To date, the optimal treatment for cardiac
disease in patients with ESRD remains unknown. According
to our research, no randomized controlled trial specifically
addressing this debate has been reported. A previous study
suggested using CABG over percutaneous coronary inter-
vention (PCI) for complete revascularization because CABG
has an extensive atherosclerotic nature and provides a
higher chance for renal transplantation in the future.4
However, in recent decades, the use of PCI has
increased,1 despite evidence of more favorable long-term
outcomes in patients with ESRD after CABG compared
with those in these patients after medical management or
PCI. In other words, an increasing number of patients with
ESRD and stable multivessel CAD have undergone PCI as a
treatment option. With advancements in technology, a
decreased risk of complications and a higher success rate
can be achieved, which is crucial given the foreseeable
need for repeat revascularization.
Advancements in CABG surgery have lowered operative
morbidity and mortality rates. In addition, cardiac surgery
has become considerably safer for patients with ESRD in
recent years; however, their overall prognosis remains
poor.1 The perioperative risks involved in cardiac surgery
are higher in patients with ESRD than in the general cardiac
patient population, possibly because of multiple extrac-
ardiac comorbidities such as ventricular hypertrophy, ce-
rebrovascular and peripheral artery disease, infection,
electrolyte disturbance, anemia, cachexia, and increased
oxidative stress.5 Ko et al6 reported an overall mortality
rate of 9% in 296 patients with ESRD who underwent car-
diopulmonary bypass (CPB) procedures. According to the
American College of Cardiology and American Heart Asso-
ciation guidelines, CABG can be performed in select dialysis
patients, with an increased but acceptable risk of periop-
erative morbidity and mortality.
3. Off-pump CABG versus on-pump CABG
The increased operative risk in ESRD patients undergoing
cardiac surgery is mostly due to preexisting multisystem
diseases, generalized atherosclerosis, heavily calcified
aorta and coronary arteries, complicated intraoperative
and postoperative management, and bleeding tendency.
Off-pump coronary artery bypass (OPCAB) seems intuitively
simpler and less invasive for hemodialysis (HD)-dependent
patients. Manabe et al7 suggested a physiological basis for
supporting OPCAB in HD patients; they reported an
improvement in cardiac hemodynamics in terms of a post-
operative decrease in the right atrial and pulmonary
capillary wedge pressure and postoperative lung oxygena-
tion in patients who underwent OPCAB compared with
those who underwent on-pump CABG. Moreover, the
application of newly developed surgical equipment, such as
stabilizers, has facilitated coronary anastomoses on the
beating heart, thus avoiding the need for CPB surgery and
preventing subsequent inflammatory responses, fluid over-
load, electrolyte imbalance, and aggravated bleedingdisorders in patients with uremia. In addition, with less
manipulation of the ascending aorta, postoperative neuro-
logical complications might be decreased.
Although patients who have undergone revascularization
through CPB demonstrated a marked increase in operative
mortality compared with patients who have undergone
OPCAB, the improved perioperative mortality did not show
equivalent or more favorable survival in the long-term
follow-up.8 A study investigated the shorter longevity in
OPCAB patients who survived the perioperative period
(Figure 1).8 In addition, using data from the United States
Renal Data System database in a comorbidity-adjusted Cox
model, Beckermann et al9 investigated 3922 patients who
underwent either OPCAB or on-pump CAB. They reported
an association of OPCAB with morbidity benefits and a 16%
decrease in all-cause mortality.
Several institutional reports have indicated that the off-
pump technique provides a significant reduction in the
morbidity associated with CABG. In a larger study, Shroff
et al10 enrolled 13,085 dialysis patients undergoing first
CABG surgery and observed a considerable improvement
early after OPCAB. Therefore, we believe that fewer grafts
and incomplete revascularization are the key drawbacks in
off-pump patients, due to technical challenges. Long-term
survival is significantly more favorable in on-pump patients,
possibly because of incomplete revascularization.
In our institution, OPCAB is not a risk factor for late
death. We believe that even in dialysis patients, revascu-
larization can be performed using the off-pump approach
with high anastomosis quality.11 In conclusion, compared
with conventional CPB surgery, off-pump revascularization
may provide superior perioperative morbidity and mortality
in dialysis patients.4. Single internal mammary artery versus
bilateral internal mammary artery versus
saphenous vein graft only: Long-term survival
Internal mammary artery (IMA) grafts provide superior
benefits compared with other CABG grafts. IMA grafting for
Figure 2 Estimated freedom from major adverse cardiac
events in the KaplaneMeier model for patients whose left
anterior descending (LAD) artery was revascularized with the
internal thoracic artery (ITA) ipsilateral to the arteriovenous
fistula (ipsilateral group, dotted line) and for patients whose
LAD artery was grafted with the ITA opposite to the fistula
(contralateral group, solid line). Note. From “Effects of the
side of arteriovenous fistula on outcomes after coronary artery
bypass surgery in hemodialysis-dependent patients,” by Y.
Takami, K. Tajima, W. Kato, et al., 2014, J Thorac Cardiovasc
Surg, 147, p. 619e624.
Coronary artery revascularization in CAD patients 47lesions of the left anterior descending (LAD) coronary ar-
tery is preferable whenever indicated and technically
feasible.12 In patients requiring long-term dialysis, the
benefit of IMA grafting is more notable because of the high
resistance of the IMA to atherosclerosis, intimal hyperpla-
sia, and medial calcification.13
Although dialysis patients often have calcification in
their coronary arteries, aorta, and other peripheral ar-
teries, chronic renal failure has a minimum effect on
atherosclerotic changes in the IMA. Furthermore, in 170
dialysis patients who underwent CABG, Hsu et al14 reported
an acceptable operative mortality rate of 8.2%, which was
more satisfactory than that in the natural course of dialysis-
dependent patients with renal failure. In addition, they
reported that the use of the left IMA graft was a significant
predictor of operative or long-term mortality. Most late
deaths were due to infection or cardiac events. In a
retrospective study, Bechtel et al15 reported that using an
IMA graft, having sinus rhythm, and undergoing renal
transplantation were associated with longer survival in
patients with ESRD undergoing CABG.
The use of bilateral IMA (BIMA) in dialysis patients is
controversial. Because of poor wound healing and increased
bleeding following IMA grafting, this technique was previ-
ously assumed to be ruled out in renal dialysis patients.
Some studies13,16 have reported significantly more favor-
able long-term results in terms of cardiac-related events
and freedom from cardiac mortality in BIMA patients, at the
expense of greater chest tube drainage volume or possibly
larger blood transfusions.16 Therefore, harvesting the IMA
in a skeletonized manner is preferred to prevent media-
stinitis, particularly in patients with ESRD.Copyright 2014, Yoshiyuki Takami, M.D., Ph.D. Reprinted with
permission.5. Steal syndrome
Another concern is the effect of the in situ IMA graft ipsi-
lateral to the arteriovenous (AV) fistula on outcomes
following CABG in dialysis-dependent patients. Successful
revascularization of the LAD is always considered as the key
factor for clinical outcomes in patients with ESRD and in
nondialysis patients. In situ harvesting of the left IMA (LIMA)
decreases the manipulation of the atherosclerotic
ascending aorta, which is a potential source of systemic
emboli after proximal anastomosis.
However, a risk of coronary steal persists, which may
lead to a dynamic decrease of the ipsilateral IMA flow as a
potential cause of poor outcomes in patients with ESRD
following CABG. Gaudino et al17 observed a hemodynami-
cally evident in situ LIMA flow steal and consequent
myocardial hypokinesia on transthoracic echocardiography
during HD in five patients with ipsilateral AV fistula and IMA
graft. Possible risk factors include altered IMA anatomy,
subclavian stenosis, anatomical AV fistula location, and
progressively increased blood flow through the AV fistula
with time.
By contrast, several studies5,18 have reported no signif-
icant changes in survival (Figure 2) or Doppler flow of the
ipsilateral or contralateral IMA with the occluded AV fistula
during HD. A poorer prognosis in dialysis patientsundergoing CABG is associated with more diffuse CAD with
poor runoff but not with the side of the IMA graft and the
LAD steal on the same side as the AV fistula. Compared with
the contralateral group, revascularization did not increase
operative mortality or risks of late death and cardiac events
after isolated CABG in dialysis patients. We do not generally
use the ipsilateral IMA if patients undergoing HD have a high
flow through the AV fistula.6. Conclusions and future research directions
Appropriate treatment decisions can be made for managing
cardiovascular disease in the general population. However,
making evidence-based decisions for the management of
patients with concurrent renal disease is difficult.
The potential long-term benefits of CABG may differ in
patients with ESRD compared with the general population,
and the perioperative risk of death may be
unacceptably high. Nonetheless, CABG has long been the
dominant revascularization strategy in selected patients in
our institute for multivessel diseases. Additional research
will raise the awareness of surgeons for making appropriate
patient-related decisions regarding coronary artery
revascularization.
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